tradingkey.logo

Ascendis Pharma A/S

ASND
View Detailed Chart

170.440USD

+3.859+2.32%
Close 04/30, 16:00ETQuotes delayed by 15 min
10.34BMarket Cap
LossP/E TTM

Ascendis Pharma A/S

170.440

+3.859+2.32%
Intraday
1m
30m
1h
D
W
M
D

Today

+2.32%

5 Days

+7.78%

1 Month

+10.26%

6 Months

+38.77%

Year to Date

+23.80%

1 Year

+23.11%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 17 analysts
BUY
Current Rating
207.625
Target Price
24.64%
Rising Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

561
Total
5
Median
6
Average
Company name
Ratings
Analysts
Ascendis Pharma A/S
ASND
17
CRISPR Therapeutics AG
CRSP
29
Intellia Therapeutics Inc
NTLA
28
Regeneron Pharmaceuticals Inc
REGN
28
Moderna Inc
MRNA
27
Exact Sciences Corp
EXAS
27
1
2
3
...
112

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Buy
Sell(1)
Neutral(0)
Buy(9)
Indicators
Sell(1)
Neutral(0)
Buy(3)
Indicators
Value
Direction
MACD(12,26,9)
1.819
Buy
RSI(14)
70.246
Buy
STOCH(KDJ)(9,3,3)
89.578
Overbought
ATR(14)
8.022
Low Volatility
CCI(14)
131.926
Buy
Williams %R
2.306
Overbought
TRIX(12,20)
0.757
Sell
StochRSI(14)
100.000
Overbought
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
165.300
Buy
MA10
162.812
Buy
MA20
154.608
Buy
MA50
141.223
Buy
MA100
136.377
Buy
MA200
135.202
Buy

News

More news coming soon, stay tuned...

Company

Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).
Company codeASND
CompanyAscendis Pharma A/S
CEOMr. Jan Moller Mikkelsen
Websitehttps://ascendispharma.dk/